Abstract
Bone defect repair requires bone mineralization, during which amorphous calcium phosphate (ACP) plays a critical role in the formation and phase transformation of bone apatite. ACP-based biomaterials continuously release calcium and phosphate, promoting the deposition and maturation of bone minerals. This effectively overcomes the limitations of insufficient osteoinductivity of crystalline calcium phosphate (CaP) phases such as hydroxyapatite (HA). However, the instability of ACP leads to its spontaneous conversion into stable CaP phases, reducing its inherent osteogenic potential. Therefore, stabilizing ACP to maintain its bioactivity is crucial for bone repair biomaterials. Inspired by the bone biomineralization and the natural stabilization of ACP by citrate in bone, we developed a porous biomimetic mineralized scaffold (POC-ACP) using citrate-based poly (octamethylene citrate) (POC) to stabilize ACP for bone defect repair. The stabilized ACP acted as a mineralization seed, initiating the bone mineralization process and promoting new bone formation. Meanwhile, its excellent mechanical and porous structure supported cell and tissue ingrowth. Compared to the POC-HA scaffold, the POC-ACP scaffold significantly enhanced osteogenesis and angiogenesis both in vitro and in vivo. Mechanistically, RNA-sequencing elucidated that the POC-ACP scaffold promoted osteogenic differentiation by activating the AMPK and TGF-β signaling pathways. Our study provides a novel biomimetic mineralized scaffold with ACP stabilization, offering a promising alternative for clinical bone defect repair.